Filing Flows › Opus Genetics (IRD) › Next earnings date
Opus Genetics (IRD) earnings on Nov 11, 2026: what to expect
Opus Genetics (IRD) is expected to report earnings on Nov 11, 2026 (estimated), in 3 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.15 (−$0.21 to −$0.09, 12 estimates) on revenue of $2.1M, against −$0.25 and $3.1M a year ago. It beat the EPS estimate in 25% of the quarters on record; Filing Flows' model gives it a 51% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.25 on revenue of $1.6M, against the analysts' −$0.15.
The last report
Opus Genetics reported revenue of $755K for the second quarter 2026 (-74% Y/Y), net loss $8.1M. How it makes money → · Every quarter →
Opus Genetics' latest quarter
Opus Genetics, Q2 2026: revenue $755K (-74% year over year), net loss $8.1M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.
Questions
When does IRD report earnings?
Opus Genetics is expected to report on Nov 11, 2026 (estimated).
What are analysts expecting from Opus Genetics?
EPS of −$0.15 and revenue of $2.1M for the quarter.
Does Opus Genetics usually beat earnings?
It beat the consensus EPS estimate in 25% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.